Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis

Diagn Microbiol Infect Dis. 2007 Jan;57(1):105-7. doi: 10.1016/j.diagmicrobio.2006.10.019.

Abstract

This study assessed daily aspirate samples from an indwelling sinus catheter during high-dose, short-course levofloxacin (750 mg daily x 5 days) treatment of acute maxillary sinusitis. Pathogens were isolated from 4 of 18 recruited patients. Bacteriologic eradication occurred within 24 h for 3 patients and 72 h for the 4th.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use
  • Catheters, Indwelling*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Haemophilus Infections / drug therapy
  • Haemophilus Infections / microbiology
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / isolation & purification
  • Humans
  • Levofloxacin*
  • Male
  • Maxillary Sinusitis / drug therapy*
  • Maxillary Sinusitis / microbiology*
  • Microbial Sensitivity Tests
  • Middle Aged
  • Moraxella catarrhalis / drug effects
  • Moraxella catarrhalis / isolation & purification
  • Moraxellaceae Infections / drug therapy
  • Moraxellaceae Infections / microbiology
  • Ofloxacin / administration & dosage*
  • Ofloxacin / adverse effects
  • Ofloxacin / therapeutic use
  • Pneumococcal Infections / drug therapy
  • Pneumococcal Infections / microbiology
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / isolation & purification
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Levofloxacin
  • Ofloxacin